In a previous study, two proteins identified as hyaluronidases were detected in spent media by MS and found to be in greater quantity in the sarA and sarA agr mutant strains when compared with the parent and agr mutant strains of Staphylococcus aureus UAMS-1. In the present study, spent media and total RNA were isolated from UAMS-1 and its regulatory mutants and analysed for hyaluronidase activity and steady-state hyaluronidase (hysA) RNA message levels. Hyaluronidase activity was observed throughout all time points examined regardless of the regulatory effects of sarA and agr but activity was always substantially higher in the sarA and sarA agr mutant strains than in the UAMS-1 parent and agr mutant strains. Northern analysis did not detect hysA message for either the UAMS-1 parent or the agr mutant strains at any time point examined, while steady-state hysA message levels were detected throughout growth for the sarA mutant strain, but only at exponential and early post-exponential growth for the sarA agr mutant strain. An in vitro biofilm plate assay, pre-coated with human plasma as a source of hyaluronic acid, demonstrated no significant increase in biofilm for a sarA mutant strain of S. aureus UAMS-1 defective in hyaluronidase activity when compared with the sarA mutant strain. These data indicate that, while hysA message levels and hyaluronidase activity are elevated in the sarA mutant strains of S. aureus UAMS-1, the increase in activity did not contribute to the biofilm-negative phenotype observed in the sarA mutant strain of S. aureus UAMS-1.
INTRODUCTION
Staphylococcus aureus is a Gram-positive bacterium of both community-associated and hospital-acquired diseases that accounts for 14.9 and 18.8 % of all bacterial infections encountered in the clinical setting as either outpatient or inpatient cases, respectively (Styers et al., 2006) . Just as important and of great concern is the continual rise in the number of meticillin (oxacillin)-resistant S. aureus (MRSA) encountered in the hospital setting and now in the community (Diekema et al., 2001; Loffler & MacDougall, 2007; Saïd-Salim et al., 2003; Styers et al., 2006) . This concern is compounded further by the occurrence of clinical strains resistant to intermediate (Hiramatsu et al., 1997; Srinivasan et al., 2002) and high (Chang et al., 2003; Tenover et al., 2004; Whitener et al., 2004 ) levels of vancomycin, an antibiotic of last resort for infections involving multiple antibiotic-resistant, hospital-acquired MRSA (Maple et al., 1989) .
As an aid to the discovery of new potential targets for the development of alternative approaches for the prevention and treatment of staphylococcal diseases, a number of laboratories have utilized whole-genome sequencing and microarray and proteomic technologies to generate comprehensive databases of S. aureus (Hecker et al., 2003;  Bacterial hyaluronidases (also referred to as hyaluronate lyase) are a group of enzymes that degrade hyaluronic acid (HA) but also have limited ability to degrade chondroitin and chondroitin sulfate (Hynes & Walton, 2000; Stern & Jedrzejas, 2006) . HA is a linear unsulfated glycosaminoglycan polymer made up of b1-4 alternating units of Dglucuronic acid-[1-3]-b-N-acetylglucosamine (Hynes & Walton, 2000; Stern & Jedrzejas, 2006) . This polymer is a major component of the extracellular matrix of human tissues (e.g. amniotic fluid, articular cartilage, blood, brain, liver, plasma, skin, synovial fluid and umbilical cord) and it is a versatile component of many physiological processes, including cell proliferation, differentiation, migration and adhesion, as well as inflammation, wound healing, water homeostasis and viscoelasticity of the extracellular matrix (Girish & Kemparaju, 2007) . Hyaluronidases have been found in a variety of Gram-positive and Gram-negative bacteria and a number of these have been implicated in the disease process as a way to invade and penetrate tissues (Hynes & Walton, 2000) . For example, the assumption has been that the glycoside hydrolase activity exhibited by hyaluronidase (Mu toxin) and other toxins produced by Clostridium perfringens contributes to virulence by destroying connective tissue, which promotes dissemination of the organism and/or facilitates the action of the more potent btoxin (Rood & Cole, 1991; Smith, 1979) . However, the exact role of the clostridial hyaluronidase in virulence has not been determined even though the gene (nagH) for HA degradation has been cloned and sequenced (Canard et al., 1994) and the catalytic portion of one (Ficko-Blean & Boraston, 2005) of the four known homologues (Shimizu et al., 2002) has been crystallized. More recently, Starr & Engleberg (2006) demonstrated, using two clinical isolates of Streptococcus pyogenes and their corresponding hyaluronidase-defective mutant strains, that hyaluronidase facilitated the dissemination of dextran blue but not Strep. pyogenes cells in a mouse model of abscess formation. This allowed Starr & Engleberg (2006) to hypothesize that streptococcal hyaluronidase activity may provide the micro-organism with a potential source of energy, a hypothesis supported by the fact that Strep. pyogenes parental strains were able to use HA as a sole source of carbon while hyaluronidase mutants were not. Others have also reported a role for hyaluronidase both in disease and in the acquisition of a suitable carbon and energy source (Cheng et al., 1995; Homer et al., 1997; Shain et al., 1996) .
In a previous study, hyaluronidase expression in S. aureus 8325-4 was shown to be activated by agr and repressed by sarA, as determined by hyaluronidase-specific activity in spent media (Makris et al., 2004) . This study also showed that a mutation in the hyaluronidase gene resulted in reduced virulence in a mouse abscess model. However, these studies were conducted with S. aureus 8325-4, a laboratory strain known to contain a deletion within the rsbU gene (Kullik et al., 1998) . The product of the rsbU gene is involved in regulating the activity of SigB (Gertz et al., 2000; Giachino et al., 2001; Pané-Farré et al., 2006; Senn et al., 2005) , which is the post-exponential sigma factor in S. aureus that controls the expression of numerous S. aureus virulence factors (Kullik et al., 1998) . In addition, DNA genomic databases indicate that at least five S. aureus strains contain two open reading frames (ORFs) identified as genes for hyaluronidase (Kersey et al., 2005) whereas S. aureus 8325 and the remaining sequenced strains contain only one gene identified as hyaluronidase (Kersey et al., 2005) . Given the aforementioned observations and our previous proteomic studies that identified two proteins as hyaluronidases whose abundance was greater in the sarA and sarA agr mutant strains (Jones et al., 2008) , we decided to assess the regulatory role of sarA and agr for hyaluronidase in S. aureus strain UAMS-1. This is a clinical strain isolated from a patient with osteomyelitis (Gillaspy et al., 1995) and does not have an rsbU mutation; it is thus safe to assume that this strain is not deficient in SigB activity (Cassat et al., 2006) . In addition, because hyaluronidase has been shown to be involved in biofilm dispersal in Streptococcus intermedius (Pecharki et al., 2008) and sarA mutant strains of S. aureus are known to be deficient in biofilm formation (Beenken et al., 2003; Valle et al., 2003) as well as to express elevated amounts of hyaluronidase (Jones et al., 2008; Makris et al., 2004) we examined whether S. aureus hyaluronidase is involved in biofilm formation and/ or dispersal.
METHODS
Strains and growth conditions. Strains and plasmids used in this study are listed in Table 1 . Overnight (15-18 h) cultures of S. aureus, grown in trypticase soy broth (TSB; Difco Laboratories) containing the appropriate antibiotic [either 50 mg ml 21 each of kanamycin or neomycin (both Sigma) for the sarA mutant strain, 5 mg tetracycline ml 21 (Sigma) for the agr mutant strain, or all three antibiotics for the sarA agr mutant strain], were harvested by centrifugation, washed twice in sterile TSB and used to inoculate sterile TSB without antibiotic. Flasks were incubated at 37 uC with rotary aeration (180 r.p.m.) and growth was monitored spectrophotometrically at 550 nm.
Spent media and cell lysate preparation. Spent media were prepared in two ways. For comparison of S. aureus UAMS-1 and its regulatory mutant strains at various points in growth, spent media were prepared as described by Jones et al. (2008) except precipitation with trichloroacetic acid (TCA) was excluded as staphylococcal hyaluronidase activity is sensitive to TCA (data not shown). Briefly, 40 ml cultures were standardized using optical density determinations with sterile TSB as diluent. Cells were harvested by centrifugation (12 000 g, for 10 min at 4 uC) and spent media were filter-sterilized, quick-frozen with dry ice and ethanol, and stored overnight at 280 uC. Frozen spent media were lyophilized to dryness, reconstituted with water at one-tenth the original volume and combined. Spent media were further concentrated using ultrafiltration [Amicon Ultra-4 filters with 3000 kDa molecular weight cut-off (MWCO); Millipore] and overnight centrifugation (2000 g) at 4 uC. The retentates were recovered and stored at 280 uC until needed.
Spent media prepared for comparative purposes among S. aureus strains were prepared as described by Hart et al. (2009) . Briefly, cell density values of overnight cultures (15-18 h) were determined spectrophotometrically at 550 nm and used to dilute each culture to an optical density reading of 3.0 with freshly prepared and sterilized TSB. Cells were pelleted by centrifugation (10 000 g, for 10 min at 4 uC) and spent media were filter-sterilized and concentrated by centrifugation (7500 g) for 1 h using ultrafiltration (Centricon Ultracel YM-3 filters with 3000 kDa MWCO; Millipore). Retentates were stored at 280 uC until used.
Cell lysates from Escherichia coli strains containing the appropriate hysA plasmid clones were prepared as described by Blevins et al. (2002) . Briefly, cultures were standardized using optical density determinations at 550 nm and sterile TSB as diluent. Portions of 3 ml were removed for isolation of plasmids, and cells from the remaining culture volume were harvested by centrifugation (12 000 g, for 10 min at 4 uC), washed in an equal volume of TE (10 mM Trisbase, 1 mM EDTA, pH 7.5) buffer and suspended in 0.4 ml of TE. Cell suspensions were pipetted into FastPROTEIN TM BLUE tubes (MP Biochemical) containing silica beads and cells were lysed using a Fast Prep FP120 reciprocator (MP Biochemical) at 6 m s 21 for 40 s. Cell lysates were cooled on ice for 15 min followed by centrifugation (10 000 g for 1 min at 4 uC). The supernatants were collected and frozen at 280 uC until used.
PCR and hysA cloning. Primers (Table 2) for hysA amplification were designed using the completed genome sequence of S. aureus Sanger 252 . Chromosomal DNA isolated from S. aureus Sanger 252 and UAMS-1 was used as template and PCR was conducted with the high-fidelity Platinum Taq DNA polymerase as instructed by the manufacturer (Invitrogen). Amplicons (ca. 4.0 kbp in size) consisting of the ORF and approximately 1000 bases up-and downstream were cloned into pCR4-TOPO (Invitrogen) and transformed into E. coli TOP10 (Invitrogen). Transformants resistant to carbenicillin (100 mg ml 21 ) and exhibiting a white to light blue colonial appearance on tripticase soy agar (TSA) containing X-Gal were procured. Plasmids were isolated using a Qiagen Plasmid Mini kit (Qiagen Inc.), amplicon orientation was determined by restriction endonuclease digestion and the identity of the amplicon was confirmed by sequencing the 59 and 39 ends of each cloned insert. hysA mutation. Allelic replacement was accomplished using the method described by Bae & Schneewind (2006) and primers (Table 2) designed from the genomic DNA databases of S. aureus Sanger-252 and S. aureus FPR3757 (USA300) (Diep et al., 2006) . Primers hysA1FattB1 and hysA1RSacII and primers hysA1FSacII and hysA1RattB2 were used to generate 628 and 723 bp amplicons, up-and downstream of the ORF of hysA1, respectively. Likewise, primers hysA2FattB1 and hysA2RSacII and primers hysA2FSacII and hysA2RattB2 were used to generate 603 and 769 bp amplicons, up-and downstream of the ORF of hysA2, respectively. Amplicons were digested with SacII and the appropriate amplicon pairs were ligated prior to lambda-mediated integration into plasmid pKOR1 using the Gateway BP Clonase system (Invitrogen). Integration products were transformed into E. coli DH5a, and plasmids isolated from colonies growing in the presence of carbenicillin (100 mg ml 21 ) were verified to contain the appropriate insert by PCR. Plasmids were then transformed into S. aureus RN4220 by electroporation and subsequently moved into S. aureus UAMS-1, Sanger-252 and USA300 (Miss) by w11-mediated transduction. Plasmid-bearing strains were grown overnight at 43 uC in the presence of chloramphenicol (10 mg ml 21 ), followed by a second overnight incubation at 43 uC in the presence of chloramphenicol (7.5 mg ml 21 ). Cultures were then diluted and plated on TSA containing chloramphenicol (10 mg ml 21 ) and incubated again at 43 uC. Isolated colonies were inoculated into TSB containing chloramphenicol (10 mg ml 21 ) and incubated overnight at 30 uC to promote plasmid excision. Cultures were again diluted and plated on TSA containing anhydrotetracycline (1.0 mg ml 21 ) to select for hysA deletion mutants devoid of plasmids.
RNA isolation and Northern analysis. Isolation of total RNA was done as described by Hart et al. (1993) . Twofold serial dilutions were made from 5 mg of isolated RNA and denatured in the presence of glyoxal and DMSO. RNA was resolved by agarose gel electrophoresis and transferred onto neutral nylon membranes (MagnaGraph; Micron Separations) by passive diffusion. Membranes were hybridized overnight at 65 uC with digoxigenin (DIG) 11-UTP (Roche Molecular Biochemicals) -labelled probes of amplicons generated by PCR using either S. aureus UAMS-1 or RN6390 (8325 lineage) chromosomal DNA as template and primers hysAF and hysAR (Table  2) designed from the known genomic sequence of S. aureus N315. Hybridizing probes were detected by autoradiography using alkaline phosphatase-conjugated antidigoxigenin F(ab9) 2 antibody fragments (Roche Molecular Biochemicals) and the chemiluminescent substrate CDP-Star (Roche Molecular Biochemicals). Membranes were then stripped accordingly (Roche Molecular Biochemicals) and hybridized with a DIG-labelled DNA probe specific for 16S rRNA (Snodgrass et al., 1999) to ensure equal RNA loading and transfer to membranes between samples.
HA plate assay for the detection of hyaluronidase activity.
Hyaluronidase activity was determined using the method described by Steiner & Cruce (1992) with modifications described by Hart et al. (2009) . Briefly, 1 % (w/v) BSA (Fraction V; Fisher Scientific), and 0.8 mg HA ml 21 (Sigma, H-1504; potassium salt, from human umbilical cord) in 0.3 M sodium phosphate buffer (pH 5.3) and 1 % (w/v) SeaKem LE agarose (Cambrex BioScience) were poured into sterile plastic square plates and allowed to solidify. Wells (4 mm diameter) were made aseptically, and spent medium (20 ml) was pipetted into each well. Plates were flooded with 2 M acetic acid after overnight (15-18 h) incubation at 37 uC. Zones of clearing were visualized against a background of opaque precipitated HA conjugated to BSA and their diameters were measured in millimetres. Purified bovine testicular hyaluronidase (Sigma, H-3506) was used as a positive control.
Biofilm microtitre plate assay. Biofilm formation was determined using 96-well flat bottom plates (Costar; Corning Inc.) as described by Beenken et al. (2003) except that S. aureus strains were grown without antibiotic selection in either filter-sterilized TSB (Difco) or filtersterilized TSB supplemented with 0.5 % (w/v) glucose and 3.0 % (w/v) NaCl. TSB containing glucose and NaCl has been shown to enhance biofilm formation in S. aureus (Beenken et al., 2003; Götz, 2002) . Overnight (15-18 h) cultures were diluted to an OD 550 of 0.05 with fresh media and dispensed as 0.2 ml portions into each well, which had been coated overnight at 4 uC with 20 % human plasma (Sigma, P-9523). Plates were then incubated overnight (ca. 24 h) at 37 uC prior to cell suspension removal and subsequent washing of wells with sterile PBS. Biofilm in each well was stained with 0.2 ml of crystal violet [0.4 % (w/v) in water], washed with water and allowed to dry overnight. Stained biofilm was suspended in 0.2 ml of acid alcohol (40 % ethanol and 10 % acetic acid in water) and diluted 10-fold in water to ensure all optical density values fell within the linear portion of a standard curve of optical density as a function of increasing concentrations of crystal violet. Diluted biofilm suspensions were quantified using a SpectraMax Plus 384 plate reader 
RESULTS
Relative hyaluronidase activity of S. aureus strains UAMS-1 and Newman and their corresponding regulatory mutant strains Spent media isolated from overnight (15-18 h) cultures of S. aureus strains UAMS-1 and Newman and their corresponding regulatory mutant strains and diluted to OD 550~3 were analysed for hyaluronidase activity using the HA plate assay (Table 3 ). Hyaluronidase activity of the S. aureus UAMS-1 sarA and sarA agr mutant strains gave zones of clearing approximately twice that of the UAMS-1 wild-type and its agr mutant strain (Table 3) . Similar results were also observed with S. aureus Newman and its isogenic sarA and agr mutant strains (Table 3) .
hysA mutant strains of S. aureus UAMS-1, Sanger-252 and USA300 (Miss)
In our previous study (Hart et al., 2009 and Table 3) hyaluronidase activity and the number of hysA genes present were determined for two pulsed-field type USA300 strains (LAC and Miss). Both strains exhibited similar levels of hyaluronidase activity and were shown by Southern analysis to contain probably one gene for hysA (Hart et al., 2009) . However, examination of the three available pulsedfield type USA300 genomic databases revealed that two of these strains (FPR3757 and TCH959) contain one gene for hysA (Diep et al., 2006; Highlander et al., 2007) , whereas the third strain (TCH1516) contains two (Highlander et al., 2007) . Given the clonality of the USA300 pulsed-field type (Kennedy et al., 2008) we reasoned that the DNA sequence from FPR3757 could be used to generate the hysA mutant in USA300 (Miss). It has been shown previously that S. aureus Sanger-252 and UAMS-1 are related (Cassat et al., 2005) . Therefore, the DNA sequence of the genomic database for Sanger-252 was utilized to generate the hysA1 and hysA2 mutations in Sanger-252 and to generate the mutations in UAMS-1. Utilizing these sequences, mutant strains defective in hyaluronidase activity were constructed in S. aureus UAMS-1, Sanger-252 and USA300 (Miss) using the method of Bae & Schneewind (2006) . Loss of hyaluronidase function was verified using HA plates (Table 3) . Deletion of either hysA1 or hysA2 in Sanger-252 resulted in hyaluronidase activity similar to that observed for the parent strain while the deletion of the hysA in USA300 (Miss) resulted in complete loss of hyaluronidase activity (Table 3) . Interestingly, the S. aureus UAMS-1 hysA2 mutant exhibited no detectable hyaluronidase activity, suggesting that the HysA1 protein in UAMS-1 might be defective in activity even though our previous proteomic study detected the protein in spent media (Jones et al., 2008) . To determine if the defect in hyaluronidase activity resided within the coding region of hysA1, the genes for hysA1 and hysA2 from UAMS-1 and Sanger-252 were amplified by PCR and cloned into an E. coli plasmid. Cloned amplicons (amplicons included 1000 bp up-and downstream of the ORFs) were verified by restriction endonuclease digestion and sequenced (data not shown). In addition, spent media and cell lysates from several of the E. coli clones containing plasmids with either the hysA1 or the hysA2 genes from either UAMS-1 or Sanger-252 were generated and assessed for hyaluronidase activity. All E. coli clones, except those containing the hysA1 gene from UAMS-1, exhibited activity (data not shown).
Comparative sequence analysis of the coding region of the UAMS-1 hysA1 gene with other S. aureus hysA1 genes, including the gene from Sanger-252, indicates that the UAMS-1 hysA1 gene contains a point mutation in a conserved region that results in a glutamic acid to glycine change at amino acid position 480 (data not shown). The Sanger-252 hysA1 gene cloned on a plasmid was able to restore hyaluronidase activity in the UAMS-1 hysA1 hysA2 mutant strain while the UAMS-1 hysA1 gene was not (data not shown). Hyaluronidase activity and hysA expression of S. aureus UAMS-1 and its regulatory mutant strains at various stages of in vitro growth Spent media and total RNA were isolated from S. aureus UAMS-1 and its regulatory mutants at 3, 6, 12 and 24 h and assessed for hyaluronidase activity and hysA expression (Figs 1 and 2) . Spent media were concentrated approximately 200-fold and serially diluted 10-fold prior to assessing activity. The pattern of hyaluronidase activity was similar throughout growth, in that hyaluronidase activity of the UAMS-1 parent and agr mutant strains was approximately 100-fold less than the sarA and sarA agr mutant strains (Fig. 1) . A notable change in activity at 24 h was an approximately 10-fold reduction and increase in activity for the sarA agr and agr mutant strains, respectively, as compared with activity observed at 3, 6 and 12 h (Fig. 1) . Whether these observed changes in activity at 24 h are related to the regulatory roles of sarA and agr is not known, but is currently under investigation.
Regardless of the effect of either sarA or agr, hyaluronidase activity was detected throughout growth.
When total RNA was isolated and hybridized with a probe specific for both hysA1 and hysA2, steady-state hysA message was not detected for either UAMS-1 or its agr mutant strains at any time point examined (Fig. 2) . In contrast, hysA message was detected for the sarA mutant strain at all time points and for the sarA agr mutant strain at the 3 and 6 h time points (Fig. 2) . While probes used for Northern analysis did not differentiate between hysA1 and hysA2 steady-state message levels, preliminary results obtained by real-time RT-PCR using specific probes for each gene and total RNA isolated from 3 h cultures of UAMS-1 and its mutant strains indicate comparable expression levels for hysA1 and hysA2 (data not shown).
Loss of hyaluronidase activity does not increase biofilm formation
Biofilm dispersal in Strep. intermedius was shown to involve hyaluronidase (Pecharki et al., 2008) . Because sarA mutants of S. aureus are biofilm deficient (Beenken et al., 2003; Cassat et al., 2005; Valle et al., 2003) and express hyaluronidase at elevated levels (Jones et al., 2008; Makris et al., 2004) , we postulated that the elevated levels of hyaluronidase observed in the sarA mutant background may contribute to the biofilm-negative phenotype.
Activity of hyaluronidase by S. aureus UAMS-1, Sanger-252 and USA300 (Miss) was consistently reduced when grown in TSB supplemented with glucose and NaCl ( Fig. 3 and data not shown), a reduction observed more so with the addition of glucose than with NaCl (data not shown). Nevertheless, TSB with and without glucose and NaCl was used to confirm loss of hyaluronidase activity in the UAMS-1 hysA mutant strains (Fig. 3) and to determine whether hyaluronidase contributes to the biofilm-negative phenotype of sarA mutant strains (Fig. 4) . To ensure that hyaluronidase was produced in biofilms, biofilms of S. aureus UAMS-1 and its sarA mutant strains were harvested and found to contain hyaluronidase activity (data not shown).
Regardless of the growth medium, hyaluronidase activity was not detected in either the UAMS-1 or the sarA mutant strains containing a deletion in either the hysA2 gene or the hysA1 and hysA2 genes (Fig. 3) . The lack of activity in the hysA2 mutant strain was addressed above. As with previous reports (Beenken et al., 2003; Cassat et al., 2005; Valle et al., 2003) , biofilm formation in TSB containing glucose and NaCl was always more robust than with TSB alone (Fig. 4) . Likewise with previous reports (Beenken et al., 2003; Cassat et al., 2005; Valle et al., 2003) , the UAMS-1 sarA mutant strain was significantly reduced in its ability to form a biofilm as compared with the UAMS-1 parent strain (Fig. 4) . However, contrary to our postulate, the loss of hyaluronidase activity in the UAMS-1 sarA mutant strains did not significantly increase biofilm formation when compared with the UAMS-1 sarA mutant strain alone (Fig. 4) . This was true when both TSB and TSB containing glucose and NaCl were used as growth media (Fig. 4) . Surprisingly, a significant reduction in biofilm was observed in both the hysA2 and the hysA1 hysA2 mutant strains when compared with the UAMS-1 parent strain (Fig. 4) . This significant reduction in biofilm formation was only observed in TSB and not in TSB containing glucose and NaCl. Currently, this difference may have significant implications as it relates to biofilm formation Fig. 1. Hyaluronidase activity of S. aureus UAMS-1 and its sarA, agr and sarA agr regulatory mutant strains. Spent media isolated after 3, 6, 12 and 24 h of growth were standardized with respect to optical density at each time point, concentrated and pipetted into wells either undiluted or diluted 10-, 100-or 1000-fold (10
"2 or 10 "3 , respectively).
SarA regulation of hyaluronidase and the loss of hyaluronidase activity. This phenomenon is under further investigation.
DISCUSSION
A S. aureus hyaluronidase has been purified to homogeneity and crystallized (Rautela & Abramson, 1973) , and a gene for hyaluronidase was originally cloned from S. aureus 8325-4 with an expected molecular mass of 84 kDa, which agreed with the size of the purified protein (Farrell et al., 1995) . Makris et al. (2004) has shown in S. aureus 8325-4 that hyaluronidase-specific activity occurred and reached a maximum during exponential growth. The activity determined by Makris et al. (2004) was in agreement with an earlier report by Taylor & Holland (1991) , who demonstrated that hyaluronidase-specific activity in spent media isolated from S. aureus FRI1187 increased during the exponential growth phase but gradually decreased during the post-exponential growth phase (Taylor & Holland, 1991) . Makris et al. (2004) also examined the effects of the global regulators sarA and agr on hyaluronidase-specific activity and determined that, while activity was substantially increased in an S. aureus 8325-4 sarA mutant strain, it was reduced and delayed (i.e. produced later in growth) in the agr mutant strain. In addition, staphylococcal hyaluronidase has been implicated as a virulence factor using a hysA mutant strain of S. aureus 8325-4 (Makris et al., 2004) . In this same study, both lesion severity and the number of hysA mutant cells recovered from abscesses excised after subcutaneous inoculations in mice were reduced as compared with the 8325-4 parent strain.
In our present study, hyaluronidase activity in spent media isolated from UAMS-1 and its isogenic regulatory mutant strains was detected at 3, 6, 12 and 24 h, which corresponds to the late exponential, early and late post-exponential, and stationary phases of growth (Jones et al., 2008) . While Makris et al. (2004) reported that in 8325-4 hyaluronidasespecific activity was observed to increase rapidly during exponential growth and gradually decrease with time until approximately 24 h when activity was undetectable, it is difficult to assess whether the differences observed with UAMS-1 and its mutant strains are strain related. This is particularly true given that Makris et al. (2004) determined hyaluronidase-specific activity in spent media isolated from cultures grown in a chemically defined medium (Taylor & Holland, 1989) without an apparent step to concentrate the media prior to determining hyaluronidase activity. Therefore, it is reasonable to assume that our detection of hyaluronidase activity throughout growth could be related to our medium selection or the use of concentrated spent media to assess hyaluronidase activity or both.
While hyaluronidase activity was detected for UAMS-1 and its regulatory mutant strains at all time points examined, activity was always substantially higher in the sarA and sarA agr mutant strains, suggesting that sarA has a negative regulatory effect on hyaluronidase expression. This was supported by the fact that hysA steady-state message levels were only detected in the sarA and sarA agr mutant strain Fig. 3 . Hyaluronidase activity of S. aureus UAMS-1 and its isogenic sarA and hysA mutant strains grown in either TSB or TSB supplemented with glucose (0.5 %) and NaCl (3.0 %).
backgrounds as determined by Northern analysis. The exact role of agr in the expression of hysA in UAMS-1 cannot be ascertained in the current study as hysA message was not detected for either UAMS-1 or the agr mutant strains. However, hysA message was detected for the sarA mutant strain at all four time points examined while hysA message levels for the sarA agrA mutant strain were detectable at 3 and 6 h of growth, barely detectable at 12 h, and undetected at 24 h of growth. This decrease in hysA message levels observed with the sarA agr mutant strain as compared with the sarA mutant strain suggests that agr is a positive regulator of hysA, as was reported by Makris et al. (2004) for 8325-4.
S. aureus sarA mutant strains are defective in biofilm formation (Beenken et al., 2003; Cassat et al., 2005; Valle et al., 2003) and produce elevated levels of hyaluronidase (Jones et al., 2008; Makris et al., 2004) , thermostable nuclease and a number of staphylococcal proteases (Beenken et al., 2004; Blevins et al., 2002; Cassat et al., 2006; Karlsson & Arvidson, 2002; Shaw et al., 2004) . The involvement of proteases and the thermostable nuclease (nuc) in biofilm was assessed in S. aureus UAMS-1 using sarA and nuc mutant strains in combination with a variety of inhibitors specific for certain classes (serine, cysteine and metalloproteases) of proteases produced by S. aureus (Tsang et al., 2008) . This study allowed Tsang et al. (2008) to conclude that while proteases and nuclease independently contribute to the biofilm-deficient phenotype observed in the UAMS-1 sarA mutant strain, their combined effect is significantly greater than the effect of either nuclease or proteases alone. This was clearly evident by the near wild-type levels of biofilm observed when the sarA nuc mutant strain was treated with all three protease inhibitors examined (Tsang et al., 2008) . While it appears that nuclease and proteases are major contributors to the biofilm-negative phenotype observed in the UAMS-1 sarA mutant strain, the inability to completely restore biofilm to wild-type levels when these enzymes are rendered non-functional suggests that other factors are contributory. To ascribe a role for hyaluronidase in biofilm dispersal, we assessed UAMS-1 and its isogenic regulatory mutant strains for the ability to form biofilm. This was particularly relevant given that human plasma contains HA, albeit in low quantities (10-100 ng ml 21 in healthy individuals) (Laurent & Fraser, 1992) , and that the wells of microtitre plates of the in vitro biofilm assay used in this . In vitro biofilm of S. aureus UAMS-1 (WT) and its sarA and hysA mutant strains grown in either TSB or TSB supplemented with glucose (0.5 %) and NaCl (3.0 %). Values represent the back-transformed least-squares means (n58) and their corresponding 95 % confidence limits based on two-way ANOVA of log-transformed data. All pairwise comparisons within a group (TSB or TSB+glucose+NaCl) were statistically significant (P¡0.05) unless indicated (NS, not significant).
study and others (Beenken et al., 2003) are coated with human plasma. Results from this assessment suggest that the elevated levels of hyaluronidase found in the sarA mutant strain of UAMS-1 do not contribute to the biofilm-deficient phenotype observed in this strain. However, the results could also indicate that the effect of the elevated levels of nuclease and proteases is masking the effect of hyaluronidase. Experiments are now under way to assess hyaluronidase activity and biofilm formation in strains deficient in protease and nuclease activity as well as to determine if hyaluronidase is an important component for some aspect of staphylococcal disease.
